- call +1-201-465-4211
- email sales@mrinsights.biz
Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules.
Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules. Cell therapy, genetically modified cell therapy, gene therapy and tissue engineering are the four pillars of Regenerative Medicine (RM). These therapies have the potential to beneficially alter the quality of life and improve the health of patients with cell defects, genetic diseases, neurodegenerative diseases, tissue malignancies and other medical conditions.
According to this study, over the next five years the Cell Therapy and Tissue Engineering market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Cell Therapy and Tissue Engineering business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Cell Therapy and Tissue Engineering market by product type, application, key companies and key regions.
This study considers the Cell Therapy and Tissue Engineering value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Cell Therapy
Tissue Engineering
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Cell Defects
Genetic Diseases
Neurodegenerative Diseases
Tissue Malignancies
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Betalin Therapeutics
BioCardia, Inc
BioReliance Corporation
Biosolution Co., Ltd.
Brainstorm Cell Therapeutics, Inc
MaxCyte, Inc
Medigene AG
MEDIPOST CO., Ltd.
Mesoblast Limited
Miromatrix Medical, Inc.
MolMed S.p.A
Mustang Bio, Inc
NantKwest, Inc.
Neuralstem, Inc
NexImmune, Inc.
Nohla Therapeutics, Inc
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
Rubius Therapeutics, Inc.
Sangamo Therapeutics, Inc
Voyager Therapeutics, Inc
Waisman Biomanufacturing
WindMIL Therapeutics, Inc.
Wuxi App Tec, Inc.
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cell Therapy and Tissue Engineering market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Cell Therapy and Tissue Engineering market by identifying its various subsegments.
Focuses on the key global Cell Therapy and Tissue Engineering players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cell Therapy and Tissue Engineering with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Cell Therapy and Tissue Engineering submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Cell Therapy and Tissue Engineering Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cell Therapy and Tissue Engineering Market Size 2014-2024
2.1.2 Cell Therapy and Tissue Engineering Market Size CAGR by Region
2.2 Cell Therapy and Tissue Engineering Segment by Type
2.2.1 Cell Therapy
2.2.2 Cell Therapy
2.3 Cell Therapy and Tissue Engineering Market Size by Type
2.3.1 Global Cell Therapy and Tissue Engineering Market Size Market Share by Type (2014-2019)
2.3.2 Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type (2014-2019)
2.4 Cell Therapy and Tissue Engineering Segment by Application
2.4.1 Cell Defects
2.4.2 Genetic Diseases
2.4.3 Neurodegenerative Diseases
2.4.4 Tissue Malignancies
2.4.5 Others
2.5 Cell Therapy and Tissue Engineering Market Size by Application
2.5.1 Global Cell Therapy and Tissue Engineering Market Size Market Share by Application (2014-2019)
2.5.2 Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Application (2014-2019)
3 Global Cell Therapy and Tissue Engineering by Players
3.1 Global Cell Therapy and Tissue Engineering Market Size Market Share by Players
3.1.1 Global Cell Therapy and Tissue Engineering Market Size by Players (2017-2019)
3.1.2 Global Cell Therapy and Tissue Engineering Market Size Market Share by Players (2017-2019)
3.2 Global Cell Therapy and Tissue Engineering Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cell Therapy and Tissue Engineering by Regions
4.1 Cell Therapy and Tissue Engineering Market Size by Regions
4.2 Americas Cell Therapy and Tissue Engineering Market Size Growth
4.3 APAC Cell Therapy and Tissue Engineering Market Size Growth
4.4 Europe Cell Therapy and Tissue Engineering Market Size Growth
4.5 Middle East & Africa Cell Therapy and Tissue Engineering Market Size Growth
5 Americas
5.1 Americas Cell Therapy and Tissue Engineering Market Size by Countries
5.2 Americas Cell Therapy and Tissue Engineering Market Size by Type
5.3 Americas Cell Therapy and Tissue Engineering Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Cell Therapy and Tissue Engineering Market Size by Countries
6.2 APAC Cell Therapy and Tissue Engineering Market Size by Type
6.3 APAC Cell Therapy and Tissue Engineering Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Cell Therapy and Tissue Engineering by Countries
7.2 Europe Cell Therapy and Tissue Engineering Market Size by Type
7.3 Europe Cell Therapy and Tissue Engineering Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Cell Therapy and Tissue Engineering by Countries
8.2 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Type
8.3 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Cell Therapy and Tissue Engineering Market Forecast
10.1 Global Cell Therapy and Tissue Engineering Market Size Forecast (2019-2024)
10.2 Global Cell Therapy and Tissue Engineering Forecast by Regions
10.2.1 Global Cell Therapy and Tissue Engineering Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Cell Therapy and Tissue Engineering Forecast by Type
10.8 Global Cell Therapy and Tissue Engineering Forecast by Application
11 Key Players Analysis
11.1 Betalin Therapeutics
11.1.1 Company Details
11.1.2 Cell Therapy and Tissue Engineering Product Offered
11.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Betalin Therapeutics News
11.2 BioCardia, Inc
11.2.1 Company Details
11.2.2 Cell Therapy and Tissue Engineering Product Offered
11.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 BioCardia, Inc News
11.3 BioReliance Corporation
11.3.1 Company Details
11.3.2 Cell Therapy and Tissue Engineering Product Offered
11.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 BioReliance Corporation News
11.4 Biosolution Co., Ltd.
11.4.1 Company Details
11.4.2 Cell Therapy and Tissue Engineering Product Offered
11.4.3 Biosolution Co., Ltd. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Biosolution Co., Ltd. News
11.5 Brainstorm Cell Therapeutics, Inc
11.5.1 Company Details
11.5.2 Cell Therapy and Tissue Engineering Product Offered
11.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Brainstorm Cell Therapeutics, Inc News
11.6 MaxCyte, Inc
11.6.1 Company Details
11.6.2 Cell Therapy and Tissue Engineering Product Offered
11.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 MaxCyte, Inc News
11.7 Medigene AG
11.7.1 Company Details
11.7.2 Cell Therapy and Tissue Engineering Product Offered
11.7.3 Medigene AG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Medigene AG News
11.8 MEDIPOST CO., Ltd.
11.8.1 Company Details
11.8.2 Cell Therapy and Tissue Engineering Product Offered
11.8.3 MEDIPOST CO., Ltd. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 MEDIPOST CO., Ltd. News
11.9 Mesoblast Limited
11.9.1 Company Details
11.9.2 Cell Therapy and Tissue Engineering Product Offered
11.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Mesoblast Limited News
11.10 Miromatrix Medical, Inc.
11.10.1 Company Details
11.10.2 Cell Therapy and Tissue Engineering Product Offered
11.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Miromatrix Medical, Inc. News
11.11 MolMed S.p.A
11.12 Mustang Bio, Inc
11.13 NantKwest, Inc.
11.14 Neuralstem, Inc
11.15 NexImmune, Inc.
11.16 Nohla Therapeutics, Inc
11.17 ReNeuron Group plc
11.18 Richter-Helm BioLogics GmbH & Co. KG
11.19 RoosterBio, Inc
11.20 RoslinCT
11.21 Rubius Therapeutics, Inc.
11.22 Sangamo Therapeutics, Inc
11.23 Voyager Therapeutics, Inc
11.24 Waisman Biomanufacturing
11.25 WindMIL Therapeutics, Inc.
11.26 Wuxi App Tec, Inc.
11.27 ReNeuron Group plc
11.28 Richter-Helm BioLogics GmbH & Co. KG
11.29 RoosterBio, Inc
11.30 RoslinCT
12 Research Findings and Conclusion
List of Tables and Figures
Table Product Specifications of Cell Therapy and Tissue Engineering
Figure Cell Therapy and Tissue Engineering Report Years Considered
Figure Market Research Me
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
